| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1900142 | 人凝血酶原复合物 | human prothrombin complex | Lyophilized | Biological Products(15) | New Drug Application | 2019-12-18 | 兰州兰生血液制品有限公司 | Lanzhou Lansheng Plasma-derived Biotheraples Co Ltd | In Review | 2019-12-17 | view |
| CYSB2100052 | 静注人免疫球蛋白（pH4） | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2021-01-29 | 兰州兰生血液制品有限公司 | Lanzhou Lansheng Plasma-derived Biotheraples Co Ltd | Certificate Issued | 2021-08-19 | view |